Patents Assigned to Theraclone Sciences, Inc.
  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies
    Patent number: 8609101
    Abstract: The invention provides a GM-CSF neutralizing human monoclonal antibody, 1783J22, as well as methods of making and use thereof. The monoclonal antibody is further characterized by its ability to bind epitopes from GM-CSF proteins of multiple species.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: December 17, 2013
    Assignee: Theraclone Sciences, Inc.
    Inventors: Po-Ying Chan-Hui, Steven Frey, Andres G. Grandea, III, Thomas C. Cox
  • Compositions and Methods for the Therapy and Diagnosis of Influenza
    Publication number: 20130158238
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: February 21, 2013
    Publication date: June 20, 2013
    Applicant: THERACLONE SCIENCES, INC.
    Inventor: THERACLONE SCIENCES, INC.
  • Compositions and methods for the therapy and diagnosis of influenza
    Patent number: 8460671
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: June 11, 2013
    Assignee: Theraclone Sciences, Inc.
    Inventors: Andres Grandea, III, Gordon King, Thomas Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle
  • Human Rhinovirus (HRV) Antibodies
    Publication number: 20130052163
    Abstract: The invention provides isolated fully human monoclonal anti-HRV antibodies, as well as method of making and using these antibodies. Anti-HRV antibodies of the invention prevent or treat subjects having HRV-infections, and related diseases, including, but not limited to, the common cold, nasopharyngitis, croup, pneumonia, bronchiolitis, asthma, chronic obstructive pulmonary disease (COPD), sinusitis, bacterial superinfection, and cystic fibrosis.
    Type: Application
    Filed: August 28, 2012
    Publication date: February 28, 2013
    Applicant: Theraclone Sciences, Inc.
    Inventor: Po-Ying Chan-Hui
  • Compositions and Methods for the Therapy and Diagnosis of Influenza
    Publication number: 20120315277
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: March 13, 2012
    Publication date: December 13, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Human M2e peptide immunogens
    Patent number: 8329188
    Abstract: The present invention provides novel peptide immunogens comprising influenza virus matrix 2 protein epitopes and related compositions and methods. The present invention relates to a composition comprising a peptide immunogen useful for the prevention and treatment of an influenza virus-mediated disease. The invention also relates to vaccines, immunogenic products and immunogenic compositions containing the peptide immunogens.
    Type: Grant
    Filed: November 12, 2009
    Date of Patent: December 11, 2012
    Assignee: Theraclone Sciences, Inc.
    Inventors: Matthew Moyle, Jennifer Mitcham
  • Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus Infections
    Publication number: 20120263734
    Abstract: The present invention provides novel anti-cytomegalovirus antibodies and related compositions and methods. These antibodies may be used in the diagnosis, prevention, and treatment of cytomegalovirus infection.
    Type: Application
    Filed: June 1, 2012
    Publication date: October 18, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventor: Ole Olsen
  • Human M2e Peptide Immunogens
    Publication number: 20120258077
    Abstract: The present invention provides novel peptide immunogens comprising influenza virus matrix 2 protein epitopes and related compositions and methods. The present invention relates to a composition comprising a peptide immunogen useful for the prevention and treatment of an influenza virus-mediated disease. The invention also relates to vaccines, immunogenic products and immunogenic compositions containing the peptide immunogens.
    Type: Application
    Filed: June 14, 2012
    Publication date: October 11, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventors: Matthew Moyle, Jennifer Mitcham
  • Compositions and methods for the therapy and diagnosis of cytomegalovirus
    Patent number: 8268309
    Abstract: The present invention provides novel anti-cytomegalovirus antibodies and related compositions and methods. These antibodies may be used in the diagnosis, prevention, and treatment of cytomegalovirus infection.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: September 18, 2012
    Assignee: Theraclone Sciences, Inc.
    Inventor: Ole Olsen
  • Compositions and Methods for the Therapy and Diagnosis of Influenza
    Publication number: 20120207760
    Abstract: The present invention provides compositions, vaccines, and methods for diagnosing, treating, and preventing influenza infection using a combination of antibodies raised against the influenza hemagglutinin and the matrix 2 ectodomain polypeptides.
    Type: Application
    Filed: February 14, 2012
    Publication date: August 16, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
    Publication number: 20120171218
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: August 23, 2011
    Publication date: July 5, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventors: Andres Grandea, III, Gordon King, Thomas Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
    Publication number: 20120121603
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: May 20, 2010
    Publication date: May 17, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas c. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof
    Publication number: 20120039899
    Abstract: The present invention provides novel human anti-Influenza antibodies and related compositions and methods. These antibodies are used in the prevention, inhibition, neutralization, diagnosis, and treatment of influenza infection.
    Type: Application
    Filed: August 12, 2011
    Publication date: February 16, 2012
    Applicant: THERACLONE SCIENCES, INC.
    Inventors: OLE OLSEN, CHRISTINA L. BOOZER, ANDRES G. GRANDEA, III
  • Compositions and methods for the therapy and diagnosis of influenza
    Patent number: 8114402
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: February 14, 2012
    Assignee: Theraclone Sciences, Inc.
    Inventors: Andres Grandea, III, Gordon King, Thomas Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle
  • COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF CYTOMEGALOVIRUS
    Publication number: 20110305708
    Abstract: The present invention provides novel anti-cytomegalovirus antibodies and related compositions and methods. These antibodies may be used in the diagnosis, prevention, and treatment of cytomegalovirus infection.
    Type: Application
    Filed: May 17, 2011
    Publication date: December 15, 2011
    Applicant: Theraclone Sciences, Inc.
    Inventor: Ole Olsen
  • Compositions and methods for the therapy and diagnosis of influenza
    Patent number: 8057796
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: November 15, 2011
    Assignee: Theraclone Sciences, Inc.
    Inventors: Andres Grandea, III, Gordon King, Thomas Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle
  • Compositions and methods for the therapy and diagnosis of cytomegalovirus
    Patent number: 7982012
    Abstract: The present invention provides novel anti-cytomegalovirus antibodies and related compositions and methods. These antibodies may be used in the diagnosis, prevention, and treatment of cytomegalovirus infection.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: July 19, 2011
    Assignee: Theraclone Sciences, Inc.
    Inventor: Ole Olsen
  • COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA
    Publication number: 20110033476
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: June 7, 2010
    Publication date: February 10, 2011
    Applicant: Theraclone Sciences Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Neutralizing Antibodies
    Publication number: 20100291075
    Abstract: The invention provides a GM-CSF neutralizing human monoclonal antibody, 1783J22, as well as methods of making and use thereof. The monoclonal antibody is further characterized by its ability to bind epitopes from GM-CSF proteins of multiple species.
    Type: Application
    Filed: April 23, 2010
    Publication date: November 18, 2010
    Applicant: Theraclone Sciences, Inc.
    Inventors: Po-Ying Chan-Hui, Steven Frey, Andres G. Grandea, III, Thomas C. Cox
  • COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA
    Publication number: 20100178295
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: March 17, 2010
    Publication date: July 15, 2010
    Applicant: Theraclone Sciences, Inc.
    Inventors: Andres Grandea, III, Gordon King, Thomas Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle